Global Lurasidone Hydrochloride Tablets Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Lurasidone Hydrochloride Tablets Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Lurasidone hydrochloride tablet is an antipsychotic drug that exerts a sedative effect through combined antagonism of central dopamine and serotonin receptors. Mainly used for the treatment of schizophrenia.
Lurasidone Hydrochloride Tablets report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lurasidone Hydrochloride Tablets market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Lurasidone Hydrochloride Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Lurasidone Hydrochloride Tablets key manufacturers include Sunovion, Bushu Pharma, Zhe JIANG HUA HAI Pharmaceutical Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., YANGTZE River Pharmaceutical Group Nanjing Pharmaceutical. Co., Ltd. and Jiangsu Hansoh Pharmaceutical Group Co., Ltd., etc. Sunovion, Bushu Pharma, Zhe JIANG HUA HAI Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.
Lurasidone Hydrochloride Tablets can be divided into 20mg(C₂₈H₃₆N₄O₂S·HCl) and 40mg(C₂₈H₃₆N₄O₂S·HCl), etc. 20mg(C₂₈H₃₆N₄O₂S·HCl) is the mainstream product in the market, accounting for % sales share globally in 2022.
Lurasidone Hydrochloride Tablets is widely used in various fields, such as Hospital, Retail Pharmacy, Clinic and Others, etc. Hospital provides greatest supports to the Lurasidone Hydrochloride Tablets industry development. In 2022, global % sales of Lurasidone Hydrochloride Tablets went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lurasidone Hydrochloride Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sunovion
Bushu Pharma
Zhe JIANG HUA HAI Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
YANGTZE River Pharmaceutical Group Nanjing Pharmaceutical. Co., Ltd.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Segment by Type
20mg(C₂₈H₃₆N₄O₂S·HCl)
40mg(C₂₈H₃₆N₄O₂S·HCl)
Hospital
Retail Pharmacy
Clinic
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lurasidone Hydrochloride Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lurasidone Hydrochloride Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lurasidone Hydrochloride Tablets industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Lurasidone Hydrochloride Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lurasidone Hydrochloride Tablets introduction, etc. Lurasidone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Lurasidone Hydrochloride Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Lurasidone Hydrochloride Tablets report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lurasidone Hydrochloride Tablets market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Lurasidone Hydrochloride Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Lurasidone Hydrochloride Tablets key manufacturers include Sunovion, Bushu Pharma, Zhe JIANG HUA HAI Pharmaceutical Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., YANGTZE River Pharmaceutical Group Nanjing Pharmaceutical. Co., Ltd. and Jiangsu Hansoh Pharmaceutical Group Co., Ltd., etc. Sunovion, Bushu Pharma, Zhe JIANG HUA HAI Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.
Lurasidone Hydrochloride Tablets can be divided into 20mg(C₂₈H₃₆N₄O₂S·HCl) and 40mg(C₂₈H₃₆N₄O₂S·HCl), etc. 20mg(C₂₈H₃₆N₄O₂S·HCl) is the mainstream product in the market, accounting for % sales share globally in 2022.
Lurasidone Hydrochloride Tablets is widely used in various fields, such as Hospital, Retail Pharmacy, Clinic and Others, etc. Hospital provides greatest supports to the Lurasidone Hydrochloride Tablets industry development. In 2022, global % sales of Lurasidone Hydrochloride Tablets went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lurasidone Hydrochloride Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sunovion
Bushu Pharma
Zhe JIANG HUA HAI Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
YANGTZE River Pharmaceutical Group Nanjing Pharmaceutical. Co., Ltd.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Segment by Type
20mg(C₂₈H₃₆N₄O₂S·HCl)
40mg(C₂₈H₃₆N₄O₂S·HCl)
Segment by Application
Hospital
Retail Pharmacy
Clinic
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lurasidone Hydrochloride Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lurasidone Hydrochloride Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lurasidone Hydrochloride Tablets industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Lurasidone Hydrochloride Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lurasidone Hydrochloride Tablets introduction, etc. Lurasidone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Lurasidone Hydrochloride Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices